Publication Date: Apr 15, 2026
DOL: Tsingke Unveils 'Zero-Contact' Gene Synthesis to Safeguard Core Genetic Sequences
BEIJING, April 15, 2026 /PRNewswire/ -- As the pace of biotechnology research accelerates, companies are increasingly challenged to balance rapid innovation with the protection of sensitive genetic information. Responding to this trend, Tsingke Biotech today introduced its "Zero-Contact Sequences" system—a fully automated, on-site platform designed to minimize the risk of sequence exposure while offering a practical model for secure and efficient R&D.
Stay updated with the latest industry news and expert insights.
Subscribe now to receive:
● Industry updates
● Exclusive expert insights and analysis
Enter your email to stay ahead!
